Be the first person to write a business review for Darby Dental Supply

DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.

DENTSPLY International Inc. designs, develops, manufactures, and markets dental consumable products, dental laboratory products, and dental specialty products worldwide. The company’s dental consumable products include dental sundries, such as dental anesthetics, prophylaxis paste, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride; and small equipment, including high and low speed handpieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers used in dental offices. Its dental laboratory products comprise dental prosthetics, including artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials, as well as equipment, such as computer aided machining ceramic systems, and porcelain furnaces used in the preparation of dental appliances by dental laboratories. The company’s dental specialty products consist of endodontic instruments and materials, implants and related products, bone grafting materials, 3D digital implantology, and orthodontic appliances and accessories. It primarily serves dentists, dental hygienists, dental assistants, dental laboratories, and dental schools. DENTSPLY International sells its products through distributors, dealers, and importers. DENTSPLY International Inc. was founded in 1983 and is headquartered in York, Pennsylvania.

Derma Sciences, Inc. is a specialty medical device / pharmaceutical company focused on wound care. As fully integrated manufacturer, marketer and supplier of a complete line of products for wound and skin care, we have full lines of products in the following categories: Advanced Wound Care, Traditional Wound Care, Burn Care, Skin Care and Bathing, Specialty Securement and Closure Devices, and First Aid. With two wholly owned and operated manufacturing facilities in Toronto and China, we also offer exceptional contract manufacturing services for OEM or private label products. Our company’s focus is on developing and driving sales of novel advanced wound care products, along with continuing to drive our contract manufacturing business. Regarding advanced wound care, we have built an innovative line of products that has seen quick adoption by clinicians. The line includes our market leading MEDIHONEY® line of Active Leptospermum Honey dressings, BIOGUARD™ Barrier Dressings for prophylactic infection prevention, XTRASORB™ Super Absorbent Polymer Dressings for highly exuding wounds, ALGICELL® Ag for wounds with high bioburden, and TCC-EZ™ — a gold standard total contact casting system for the management of diabetic foot ulcers.With regard to contract manufacturing, through various acquisitions over the past six years, Derma Sciences has built a strong business with broad capabilities. This strength has helped us to accelerate the growth of our private label and contract manufacturing partnerships with some of the largest distributors and wound / skin care products providers in the world. The recent addition of a First Aid line has provided strong growth to our manufacturing business, as well as the ability to take the rest of our line into the retail channel. As we look to the future, our goal is to increase our leadership position in the growing field of wound and skin care, leveraging both our key brands as well as our manufacturing capabilities, while continuing to bring next-generation products and technologies to the market.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. The company offers FDA approved SEVEN, which includes a disposable sensor that can be inserted by a patient and used continuously for up to seven days; a transmitter; and a small handheld receiver. Its SEVEN system also received CE Mark approval for commercialization in the European Union and the countries in Asia and Latin America that recognize the CE Mark. DexCom, Inc. also provides the SEVEN PLUS, which incorporates additional user interface and algorithm enhancements that are intended to make its glucose monitoring function customizable. Its SEVEN PLUS has FDA and CE Mark approvals. DexCom has a collaboration agreement with Edwards Lifesciences LLC to develop products for continuously monitoring blood glucose levels in patients hospitalized for various conditions. It also has development agreement with Insulet Corporation to integrate its continuous glucose monitoring technology into Insulet’s wireless, handheld OmniPod System Personal Diabetes Manager; and a joint development agreement with Animas Corporation to integrate its continuous glucose monitoring technology into Animas insulin pumps. DexCom, Inc. was founded in 1999 and is headquartered in San Diego, California.

Electro-Optical Sciences is seeking FDA approval, so that it can begin commercially marketing the point-of-care product to primary care physicians, dermatologists, and plastic surgeons in the US and through partnerships abroad. Electro-Optical Sciences can detect whether that mole is a sign of a more serious medical condition -- melanoma. The company's lead product is a hand-held imaging device called MelaFind, which captures images of suspicious skin lesions, compares them to other malignant and benign lesions stored in a database, and provides information about whether they should be biopsied. MelaFind is in pivotal clinical trials for its ability to detect skin cancer at an early stage.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.